arrow
L

Laura Kakkola

medicine
H指数:25
被引数:2,545

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Influenza A(H5N8) vaccine induces humoral and cell-mediated immunity against highly pathogenic avian influenza clade 2.3.4.4b A(H5N1) viruses in at-risk individuals

H5N8流感疫苗在风险个体中诱导针对高致病性禽流感分支2.3.4.4b H5N1病毒体液和细胞介导的免疫。

2025-12-050
OAAI
Corrigendum to “Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1” [Vaccine 68 (2025) 127894]

勘误:关于“疫苗和突破性感染诱导的SARS-CoV-2特异性抗体对奥密克戎亚变种BA.2、XBB.1.5和JN.1的长期中和能力” [Vaccine 68 (2025) 127894]

Vaccine
IF3.5
2025-11-070
OAAI
Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1

疫苗和突破性感染诱导的SARS-CoV-2特异性抗体对奥密克戎亚谱系BA.2、XBB.1.5和JN.1的长期中和能力

Vaccine
IF3.5
2025-10-280
OAAI
Highly Pathogenic Avian Influenza (HPAI) H5N1 virus in Finland in 2021-2023-Genetic diversity of the viruses and infection kinetics in human dendritic cells

2021芬兰的高致病性禽流感 (HPAI) H5N1病毒-2023病毒的遗传多样性和人类树突状细胞的感染动力学

2025-01-100
OAAI
The comprehensive SARS-CoV-2 'hijackome' knowledge base
2024-12-090
OAAI
Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection
2024-02-234
OA
Image-based and machine learning-guided multiplexed serology test for SARS-CoV-2
2023-08-013
OAAI
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose

第三次新型冠状病毒肺炎mRNA疫苗剂量后针对Omicron变体的持续T细胞介导的免疫反应

2023-01-2313
OAAI